Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Emerging Therapies Drive Analytical Advancements

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Analyzing Exabytes

Effective analytics will eliminate failures, deviations, and non-conformances.

Week of Aug. 9, 2010: Company and People Notes: Penwest and Endo to Merge; Watson Makes Senior Appointments; And More.

August 12, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Penwest and Endo to Merge; Watson Makes Senior Appointments; And More.

Week of August 2, 2010: Company and People Notes: FDA Approves Flu Vaccines; Caraco Names COO; And More.

August 05, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

FDA Approves Flu Vaccines; Caraco Names COO; And More.

Bioburden Method Suitability for Cleaning and Sanitation Monitoring: How Far Do We Have to Go?

August 02, 2010

The author reviews test methods for microbiological cleaning processes and suggests ways to improve microbial bioburden method suitability studies.

An Ounce of Prevention

August 02, 2010

Industry's focus on cost cutting has led to a dangerous gap in training and knowledge.

Statistical Considerations in Design Space Development (Part II of III)

August 02, 2010

The authors discuss the statistical tools used in experimental planning and stategy and how to evaluate the resulting design space and its graphical representation.

In the Spotlight August 2010

August 02, 2010

Editors' picks of pharmaceutical science and technology innovations.

Week of July 26, 2010: Company and People Notes: Merck and Sinopharm Sign Agreement; Agilent Appoints CFO; And More.

July 29, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck and Sinopharm Sign Agreement; Agilent Appoints CFO; And More.

Week of July 19, 2010: Company and People Notes: Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.

July 22, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.

FDA Joins Chemical-Screening Collaboration

July 22, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Food and Drug Administration has joined the Tox21 collaboration, which aims to develop ways to more effectively predict how chemicals will affect the body and environment.

Seeking a Dissolution-Test Solution for Inhaled Drugs

July 21, 2010

Equipment and Processing Report

The pharmaceutical industry?s increasing interest in inhaled drugs has prompted several researchers to propose standard dissolution-testing methods for these products.